Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

INSERT INTO chat_queries_log (query_id, drugname, ip, country, time_sent) VALUES ( "273196", "ruxolitinib", "216.73.217.79", "US", NOW() )

When did apotex's ruxolitinib gain usa approval?

See the DrugPatentWatch profile for ruxolitinib

When did Apotex’s ruxolitinib get US approval?

Apotex’s ruxolitinib gained US approval on July 12, 2011.[1]

Which product is this referring to?

This approval refers to an Apotex ruxolitinib product made available in the United States under the brand name Jakafi (ruxolitinib) approval history coverage in DrugPatentWatch’s database.[1]

Source

[1] https://www.drugpatentwatch.com/patent/US-8377884/apotex-inc/



Other Questions About Ruxolitinib :

What is apotex s timeline for ruxolitinib fda approval? Has apotex disclosed its ruxolitinib's fda filing intentions? Can steroids affect ruxolitinib's ability to manage symptoms? What excipients are present in apotex's ruxolitinib capsules? Has fda approved apotex's ruxolitinib generic? Drugpatentwatch com ruxolitinib paragraph iv challenges? What is the exact timeline of apotex's ruxolitinib application process?